Activating the Wnt/β-catenin pathway for the treatment of melanoma - Application of LY2090314, a Novel selective inhibitor of glycogen synthase kinase-3

Jennifer M. Atkinson, Kenneth B. Rank, Yi Zeng, Andrew Capen, Vipin Yadav, Jason R. Manro, Thomas A. Engler, Marcio Chedid

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Activating the Wnt/β-catenin pathway for the treatment of melanoma - Application of LY2090314, a Novel selective inhibitor of glycogen synthase kinase-3'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Agriculture & Biology